Location History:
- Gosforth, EN (1976)
- Newcastle-upon-Tyne, EN (1976 - 1977)
- Reading, EN (1976 - 1977)
- South Cave, EN (1977 - 1978)
- North Humberside, EN (1977 - 1978)
- Newcastle-upon-Tyne, GB (1979)
Company Filing History:
31 out of 299 
1 out of 16,083 Years Active: 1976-1979
Title: Adrian Charles Curran: Innovator in Pharmaceutical Patents
Introduction
Adrian Charles Curran, hailing from South Cave, England, is a notable inventor recognized for his significant contributions to the field of pharmaceuticals. With 32 patents to his name, Curran has made strides in developing innovative compounds aimed at addressing various medical conditions, particularly in the realm of anti-ulcer treatments.
Latest Patents
Among his latest groundbreaking inventions are the tetrahydroquinoline derivatives, which serve as intermediates useful in the preparation of anti-ulcer agents. These new derivatives contain specific structural components that include sodium, potassium, or lithium, as well as various alkyl and phenyl radicals. Additionally, Curran has patented certain 1-(N-acyl)-carbothioamides derived from 1,5-naphthyridine derivatives. These compounds also serve as intermediates for anti-ulcer agents, showcasing his focus on enhancing therapeutic options in this area.
Career Highlights
Throughout his career, Adrian Curran has worked with reputable organizations such as John Wyeth & Brother Limited and the United States of America, as represented by the Secretary of the Navy. His work within these esteemed companies has enabled him to focus on pharmaceutical innovation, leading to the development of multiple patents that contribute to medical science.
Collaborations
Curran's collaborative efforts have also played a significant role in his success as an inventor. He has had the opportunity to work alongside talented professionals like Roger Crossley and David George Hill. Together, they have advanced the research and development of pharmaceutical compounds, ensuring a significant impact on health care solutions.
Conclusion
Adrian Charles Curran stands out as a prominent figure in the world of pharmaceutical patents. With his innovative approach to developing new medical compounds, he continues to enhance treatment options available for patients. Curran's extensive patent portfolio reflects his commitment to improving health outcomes through scientific discovery and collaboration.